Skip to main content

Table 3 Factors associated with DTT in children at unadjusted and adjusted analysis using generalized linear modelling

From: Discontinuation of tuberculosis treatment among children in the Kampala Capital City Authority health facilities: a mixed-methods study

 

Univariable

Multivariable

Characteristics

Level

OR (95% CI)

aOR (95% CI)

Age categories (years)

0–5

1

 

6–10

0.46 (0.18–1.12)

 

11–15

0.69 (0.29–1.62)

 

Sex

Female

1

 

Male

1.90 (0.93–3.87)

 

Type of person with TB

New

1

 

Retreatment

2.69* (1.22–5.72)

 

Category of TB disease

PBC

1

 

PCD

0.71 (0.31–1.70)

 

EPTB

2.08 (0.79–5.50)

 

Type of DOTS

Facility

1

1

Community

0.25* (0.08–0.83)

0.33 (0.10–1.16)

Regimen

2RHZE/6HE

1

 

2RHZE/4RH

2.02 (0.90–5.18)

 

TB/HIV co-infection

No

1

 

Yes

2.43* (1.10–5.14)

 

Residence

Rural

1

 

Urban

0.55 (0.27–1.13)

 

Origin of referral

Community

1

 

Facility

0.53 (0.16–2.38)

 

Phase of treatment

Intensive

1

1

Continuation

2.01 (0.87–4.36)

5.22** (1.76–17.52)

Treatment supporter marital status

Married

1

 

Separated

1.67 (0.71–3.68)

 

Single

0.45 (0.10–1.37)

 

Treatment supporter is employed

No

1

1

Yes

1.99 (0.98–4.12)

3.60* (1.34–11.38)

Relationship between the treatment supporter and child

Grandparents

1

 

Biological parents

1.33 (0.47–4.76)

 

Other relatives

1.37 (0.44–5.20)

 

Treatment supporter received counseling at the time of TB treatment initiation

No

1

 

Yes

0.40* (0.18–0.93)

 
  1. Note: 1) BC-PTB: Bacteriologically confirmed pulmonary tuberculosis; 2) CB-DOTS: Community-based Directly Observed Therapy Short Course; 3) CD-PTB: Clinically diagnosed pulmonary tuberculosis; 4) FB-DOTS: Facility-based Directly Observed Therapy Short Course; 5) RHZE: Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol; 6) 2) Statistical significance codes at 5%: *** p < 0.001, ** p < 0.01, * p < 0.05